PENGEMBANGAN DAN VALIDASI METODE KROMATOGRAFI CAIR KINERJA TINGGI UNTUK PENETAPAN KADAR CIPROFLOXACIN DALAM SPIKED PLASMA MANUSIA DAN APLIKASINYA UNTUK UJI BIOEKIVALENSI

Ciprofloxacin is a fluoroquinolone type antibiotic agent that is being widely used for the treatment of several bacterial infections. It exhibits broad spectrum antimicrobial activity against Gram negative and Gram positive bacteria. This study aims to develop and validate an HPLC method couple with...

全面介紹

Saved in:
書目詳細資料
Main Authors: , Anggun Aji Mukti, , Dr. rer.nat. RR. Endang Lukitaningsih, M.Si., Apt.
格式: Theses and Dissertations NonPeerReviewed
出版: [Yogyakarta] : Universitas Gadjah Mada 2014
主題:
ETD
在線閱讀:https://repository.ugm.ac.id/133584/
http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=74287
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:Ciprofloxacin is a fluoroquinolone type antibiotic agent that is being widely used for the treatment of several bacterial infections. It exhibits broad spectrum antimicrobial activity against Gram negative and Gram positive bacteria. This study aims to develop and validate an HPLC method couple with a UV detection for determination of ciprofloxacin in spiked human plasma and its application for bioequivalence study. HPLC method using an RP-C18 column (Lachrom Hitachi, 250 x 4,6 mm., 5μm), mobile phase of phosphate buffer (pH 3 ± 0,1 ) : acetonitrile (87 : 13) , a flow rate of 1,5 mL / min with ultraviolet detection at 276,6 nm. The limid of detection is 0,07 μg/mL. The regression equation are linear (r > 0,999) This method was successfully applied to bioequivalence study of two product of 500 mg ciprofloxacin. For bioequivalence study was obtained (90% CI) ratio of Cmax = 74,08-124,60%, (90% CI) AUCt(0-12) ratio = 83,53-122,14 % and (90% CI) ratio AUCt(0- ) = 86,07- 120,92%.